Left Ventricular Assist Devices - Medical Devices Pipeline Assessment, 2020

Description Table of
Contents Companies Mentioned

FEATURED COMPANIES

Abbott Laboratories
Cleveland Clinic Hospital
Everheart Systems, LLC
Lonestar Heart Inc
PlugMed Heart SAS
U.S. Stem Cell Inc
MORE

Summary

The publisher's Medical Devices sector report, “Left Ventricular Assist Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Left Ventricular Assist Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

An implantable left ventricular assist device is a ventricular assist system intended for the treatment of end-stage heart failure.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Left Ventricular Assist Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Left Ventricular Assist Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Left Ventricular Assist Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date

Note: Product cover images may vary from those shown

FEATURED COMPANIES

Abbott Laboratories
Cleveland Clinic Hospital
Everheart Systems, LLC
Lonestar Heart Inc
PlugMed Heart SAS
U.S. Stem Cell Inc
MORE

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Left Ventricular Assist Devices Overview

3 Products under Development

3.1 Left Ventricular Assist Devices - Pipeline Products by Stage of Development
3.2 Left Ventricular Assist Devices - Pipeline Products by Territory
3.3 Left Ventricular Assist Devices - Pipeline Products by Regulatory Path
3.4 Left Ventricular Assist Devices - Pipeline Products by Estimated Approval Date
3.5 Left Ventricular Assist Devices - Ongoing Clinical Trials

4 Left Ventricular Assist Devices - Pipeline Products under Development by Companies

4.1 Left Ventricular Assist Devices Companies - Pipeline Products by Stage of Development
4.2 Left Ventricular Assist Devices - Pipeline Products by Stage of Development

5 Left Ventricular Assist Devices Companies and Product Overview6 Left Ventricular Assist Devices - Recent Developments7 Appendix

List of Tables

Table 1: Left Ventricular Assist Devices - Pipeline Products by Stage of Development
Table 2: Left Ventricular Assist Devices - Pipeline Products by Territory
Table 3: Left Ventricular Assist Devices - Pipeline Products by Regulatory Path
Table 4: Left Ventricular Assist Devices - Pipeline Products by Estimated Approval Date
Table 5: Left Ventricular Assist Devices - Ongoing Clinical Trials
Table 6: Left Ventricular Assist Devices Companies - Pipeline Products by Stage of Development
Table 7: Left Ventricular Assist Devices - Pipeline Products by Stage of Development
Table 8: Abbott Laboratories Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Fully Implantable Left Ventricular Assist System - Product Status
Table 10: Fully Implantable Left Ventricular Assist System - Product Description
Table 11: Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Impella 5.5 With SmartAssist - Product Status
Table 13: Impella 5.5 With SmartAssist - Product Description
Table 14: Impella BTR - Product Status
Table 15: Impella BTR - Product Description
Table 16: Impella ECP - Product Status
Table 17: Impella ECP - Product Description
Table 18: Next Generation Impella CP - STEMI - Product Status
Table 19: Next Generation Impella CP - STEMI - Product Description
Table 20: Abiomed Inc - Ongoing Clinical Trials Overview
Table 21: Impella ECP - Use of the Impella ECP in Patients Undergoing an Elective High-risk Percutaneous Coronary Intervention: An Early Feasibility Study
Table 22: Next Generation Impella CP - STEMI - Primary Unloading and Delayed Reperfusion in St-elevation Myocardial Infarction: The STEMI-DTU Trial
Table 23: Arrow International Cr, A.S. Pipeline Products & Ongoing Clinical Trials Overview
Table 24: CorAide Left Ventricular Assist System - Product Status
Table 25: CorAide Left Ventricular Assist System - Product Description
Table 26: BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: PliCath HF - Product Status
Table 28: PliCath HF - Product Description
Table 29: Calon Cardio-Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Calon MiniVAD - Product Status
Table 31: Calon MiniVAD - Product Description
Table 32: MicroVAD - Product Status
Table 33: MicroVAD - Product Description
Table 34: CardiacBooster BV Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Percutaneous Ventricular Assist Device - Product Status
Table 36: Percutaneous Ventricular Assist Device - Product Description
Table 37: CARDIAnove Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 38: CARDIAnove Pump - Product Status
Table 39: CARDIAnove Pump - Product Description
Table 40: Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview

List of Figures

Figure 1: Left Ventricular Assist Devices - Pipeline Products by Stage of Development
Figure 2: Left Ventricular Assist Devices - Pipeline Products by Territory
Figure 3: Left Ventricular Assist Devices - Pipeline Products by Regulatory Path
Figure 4: Left Ventricular Assist Devices - Pipeline Products by Estimated Approval Date
Figure 5: Left Ventricular Assist Devices - Ongoing Clinical Trials

Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

Abbott Laboratories
Abiomed Inc
Arrow International Cr, A.S.
BioVentrix Inc
Calon Cardio-Technology Ltd
CardiacBooster BV
CARDIAnove Inc
Carnegie Mellon University
Cleveland Clinic Hospital
Cleveland Heart Inc
CorAssist Cardiovascular Ltd
CorWave
Duke University
Evaheart Inc
Everheart Systems, LLC
FineHeart
HeartWare International Inc
Inspired Therapeutics LLC
Jarvik Heart Inc
LaunchPoint Technologies Inc
Leviticus Cardio Ltd
Levram Medical Systems Ltd
Lonestar Heart Inc
Mayo Clinic
Medtronic Plc
Nipro Corp
Perfusion Solution Inc
PlugMed Heart SAS
Procyrion Inc
ReliantHeart, Inc.
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Sunshine Heart Company, Pty. Ltd.
Terumo Corp
Thoratec LLC
Tokyo Medical and Dental University
U.S. Stem Cell Inc
University of Virginia
VASCOR Inc
Windmill Cardiovascular Systems, Inc.
W-Z BIOTECH, LLC
Yale University

Note: Product cover images may vary from those shown

FEATURED COMPANIES

FEATURED COMPANIES

RELATED TAGS

RELATED PRODUCTS

AXL kinase inhibitors - Pipeline Insights, 2022

Left Ventricular Assist Devices (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021

Global Ventricular Assist Devices Market 2021-2025

Global Ventricular Assist Device Market Size, Share & Trends Analysis Report by Product, by Type Of Flow (Pulsatile Flow, Continuous Flow), by Application, by Design, by Region, and Segment Forecasts, 2021-2028

Ventricular Assist Device Market Research Report by Product, Type Of Flow Outlook, Design, Application, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19